Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi

DUBLIN, April 19, 2023 /PRNewswire/ — The “Global Markets for Bioengineered Protein Drugs” report has been added to ResearchAndMarkets.com’s offering. The global bioengineered protein drugs market was estimated to have been worth $327.6 billion in 2021. Between 2022 and 2027, the…